Healthcare, economics and society – unlocking...

Send us Fan MailHow will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwid ...  Show more

Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access rou ...  Show more

Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability. Topics include:Medicare and Medicai ...  Show more

OneLondon—an ambitious project working to provide a single patient care record for 10 million people across London. Since its inception in 2018, OneLondon has evolved, connecting more healthcare providers, expanding patient access, and tackling critical challenges like end-of-lif ...  Show more

Send a message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amsterdam ...  Show more

In this insightful episode, we sit down with Maysaa Jaafar, President of the Lebanese Society for Quality and Safety in Healthcare (LSQSH), to explore the remarkable journey of the society since its inception.

Maysaa shares the story behind the establishment of LSQSH, s ...